Why is Telix Pharmaceuticals Limited (ASX:TLX) up ~10%?
Telix Pharmaceuticals (TLX) is trading ~10% higher today driven by the US FDA has approved Telix’s Pixclara (floretyrosine F18), providing the company with another commercial product in the world’s largest healthcare market.